OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment
Zhao Guo, Shuhang Wang, Guangjun Nie, et al.
Med (2024) Vol. 5, Iss. 7, pp. 660-688
Closed Access | Times Cited: 9
Zhao Guo, Shuhang Wang, Guangjun Nie, et al.
Med (2024) Vol. 5, Iss. 7, pp. 660-688
Closed Access | Times Cited: 9
Showing 9 citing articles:
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Exosome-based anticancer vaccines: From Bench to bedside
Zhao Guo, Yuning Wang, Shujun Xing, et al.
Cancer Letters (2024) Vol. 595, pp. 216989-216989
Closed Access | Times Cited: 9
Zhao Guo, Yuning Wang, Shujun Xing, et al.
Cancer Letters (2024) Vol. 595, pp. 216989-216989
Closed Access | Times Cited: 9
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 8
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 8
Exosome-based nanoparticles and cancer immunotherapy
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 5
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 5
Engineering Magnetic Extracellular Vesicles Mimetics for Enhanced Targeting Chemodynamic Therapy to Overcome Ovary Cancer
Shuai Wang, Yinghua Mao, Rong Shu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 30, pp. 39021-39034
Closed Access | Times Cited: 1
Shuai Wang, Yinghua Mao, Rong Shu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 30, pp. 39021-39034
Closed Access | Times Cited: 1
Recent Progress in Cancer Vaccines and Nanovaccines
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 1
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 1
Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine
Yang Chen, Hao Qin, Nan Li, et al.
Cell Reports Medicine (2024), pp. 101877-101877
Open Access | Times Cited: 1
Yang Chen, Hao Qin, Nan Li, et al.
Cell Reports Medicine (2024), pp. 101877-101877
Open Access | Times Cited: 1
The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy
Zhihong Sun, Rui Zhou, Jie Liu, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154506-154506
Closed Access
Zhihong Sun, Rui Zhou, Jie Liu, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154506-154506
Closed Access
Personalized Multi‐Epitope Nanovaccine Unlocks B Cell‐Mediated Multiple Pathways of Antitumor Immunity
Wenlu Yan, Ying Cao, Shanshan Xu, et al.
Advanced Materials (2024)
Closed Access
Wenlu Yan, Ying Cao, Shanshan Xu, et al.
Advanced Materials (2024)
Closed Access
